相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Autocrine stimulation of IGF1 in estrogen-induced growth of endometrial carcinoma cells: involvement of the mitogen-activated protein kinase pathway followed by up-regulation of cyclin D1 and cyclin E
Hiroyasu Kashima et al.
ENDOCRINE-RELATED CANCER (2009)
Heregulin β1 promotes breast cancer cell proliferation through Rac/ERK-dependent induction of cyclin D1 and p21Cip1
Chengfeng Yang et al.
BIOCHEMICAL JOURNAL (2008)
Deregulation of the Akt pathway in human cancer
Eriko Tokunaga et al.
CURRENT CANCER DRUG TARGETS (2008)
mTOR Pathway and mTOR Inhibitors as Agents for Cancer Therapy
Paolo Baldo et al.
CURRENT CANCER DRUG TARGETS (2008)
Advances of AKT Pathway in Human Oncogenesis and as a Target for Anti-Cancer Drug Discovery
Lu-Hai Wang et al.
CURRENT CANCER DRUG TARGETS (2008)
PI-3K/Akt pathway-dependent cyclin D1 expression is responsible for arsenite-induced human keratinocyte transformation
Weiming Ouyang et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2008)
Speeding through cell cycle roadblocks: Nuclear cyclin D1-dependent kinase and neoplastic transformation
Laura L Pontano et al.
Cell Division (2008)
Cyclin D1 in non-small cell lung cancer: A key driver of malignant transformation
Oliver Gautschi et al.
LUNG CANCER (2007)
Nitric oxide in physiologic concentrations targets the translational machinery to increase the proliferation of human breast cancer cells: Involvement of mammalian target of Rapamycin/eIF4E pathway
Shehla Pervin et al.
CANCER RESEARCH (2007)
The PI3K/Akt pathway and its downstream transcriptional factors as targets for chemoprevention
Xinhai Zhang et al.
CURRENT CANCER DRUG TARGETS (2007)
Benzo[a]pyrene diol-epoxide (B[a]PDE) upregulates COX-2 expression through MAPKs/AP-1 and IKK beta/NF-kappa B in mouse epidermal Cl41 cells
Weiming Ouyang et al.
MOLECULAR CARCINOGENESIS (2007)
Cyclooxygenase-2 induction by arsenite is through a nuclear factor of activated T-cell-dependent pathway and plays an antiapoptotic role in Beas-2B cells
Jin Ding et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Antisense to cyclin D1 inhibits vascular endothelial growth factor-stimulated growth of vascular endothelial cells: Implication of tumor vascularization
Masayoshi Yasui et al.
CLINICAL CANCER RESEARCH (2006)
Involvement of nuclear factor of activated T cells 3 (NFAT3) in cyclin D1 induction by B[a]PDE or B[a]PDE and ionizing radiation in mouse epidermal Cl 41 cells
Jin Ding et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2006)
Essential roles of PI-3K/Akt/IKKβ/NFκB pathway in cyclin D1 induction by arsenite in JB6 Cl41 cells
W Ouyang et al.
CARCINOGENESIS (2006)
Activation of phosphatidylinositol 3-kinase signaling by a mutant thyroid hormone β receptor
F Furuya et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Oncogenic PI3K and its role in cancer
Y Samuels et al.
CURRENT OPINION IN ONCOLOGY (2006)
Location, location, location: The role of cyclin D1 nuclear localization in cancer
AB Gladden et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2005)
Cyclin D1 induction through IκB kinase β/nuclear factor-κB pathway is responsible for arsenite-induced increased cell cycle G1-S phase transition in human keratinocytes
WM Ouyang et al.
CANCER RESEARCH (2005)
Carcinogenic polycyclic aromatic hydrocarbon-DNA adducts and mechanism of action
WM Baird et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2005)
Determinants of rapamycin sensitivity in breast cancer cells
WC Noh et al.
CLINICAL CANCER RESEARCH (2004)
A critical role of PI-3K/Akt/JNKs pathway in benzo[a]pyrene diol-epoxide (B[a]PDE)-induced AP-1 transactivation in mouse epidermal Cl41 cells
JX Li et al.
ONCOGENE (2004)
United at last: the tuberous sclerosis complex gene products connect the phosphoinositide 3-kinase/Akt pathway to mammalian target of rapamycin (mTOR) signalling
BD Manning et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2003)
Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases
GL Johnson et al.
SCIENCE (2002)
CYP1A1 and GSTM1 genotypes affect benzo[a]pyrene DNA adducts in smokers' lung:: comparison with aromatic/hydrophobic adduct formation
K Alexandrov et al.
CARCINOGENESIS (2002)
The role of MAPK pathways in the action of chemotherapeutic drugs
S Boldt et al.
CARCINOGENESIS (2002)
Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma
F Pene et al.
ONCOGENE (2002)
Distinct roles for phosphoinositide 3-kinase, mitogen-activated protein kinase and p38 MAPK in mediating cell cycle progression of breast cancer cells
RM Neve et al.
ONCOGENE (2002)
Cancer risk assessment, indicators, and guidelines for polycyclic aromatic hydrocarbons in the ambient air
CE Boström et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2002)
The ups and downs of MEK kinase interactions
C Hagemann et al.
CELLULAR SIGNALLING (2001)
Arsenic-induced NFκβ transactivation through Erks- and JNKs-dependent pathways in mouse epidermal JB6 cells
CS Huang et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2001)
Targeting of lung cancer mutational hotspots by polycyclic aromatic hydrocarbons
LE Smith et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
